OnKure Therapeutics, Inc.
OKUR
$4.25
-$0.15-3.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.82% | 22.58% | -27.20% | -8.85% | -67.00% |
| Total Depreciation and Amortization | -4.25% | -2.88% | 31.61% | 43.24% | 40.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.28% | 11.67% | 3,748.05% | 60.40% | 2,465.42% |
| Change in Net Operating Assets | 26.33% | 86.04% | -380.78% | -117.60% | 23.24% |
| Cash from Operations | 7.62% | 50.71% | -22.29% | -105.07% | -31.76% |
| Capital Expenditure | 72.22% | 40.00% | 66.67% | -30.00% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 72.22% | -100.06% | 66.67% | -30.00% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.59% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | 100.00% | -- |
| Cash from Financing | 189,709.09% | -99.78% | -100.00% | -100.00% | -870.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,043.66% | -110.97% | -22.19% | -2,060.49% | -32.67% |